期刊文献+

19例成骨不全症患儿肺功能分析

Pulmonary function in children with osteogenesis imperfecta of 19 cases
原文传递
导出
摘要 目的探讨Ⅲ型成骨不全患儿的肺功能指标特征.方法回顾性分析2017年1月-2017年12月天津市武清区人民医院共收治的19例Ⅲ型成骨不全患儿(成骨不全组)及非呼吸系统疾病儿童(对照组)肺功能数据.分析比较两组儿童用力肺活量(FVC)、一秒钟用力呼气量(FEV1)、第1秒钟用力呼气量占预计值的百分比(FEV1%)、第1秒钟用力呼气容积/用力肺活量(FEV1/FVC)及最大呼气流量(PEF)指标有无差异.结果两组患儿用力肺活量(FVC)、一秒钟用力呼气量(FEV1)、第1秒钟用力呼气容积/用力肺活量(FEV1/FVC)及最大呼气流量(PEF)等指标均存在明显差异.Ⅲ型成骨不全组患儿肺功能相关指标均低于对照组儿童,且有统计学差异(P<0.05).结论与对照组非呼吸系统疾病患儿相比,Ⅲ型成骨不全患儿的FVC、FEVl、PEF、FEV1/FVC等指标明显降低. Objective To investigate the characteristics of pulmonary function in children with typeⅢosteogenesis imperfecta.Methods The pulmonary function data of 19 children withⅢosteogenesis imperfecta(osteogenesis imperfecta group)and children with non respiratory diseases(control group)admitted to our hospital from January 2017 to December 2017 were analyzed retrospectively.The forced vital capacity(FVC),forced expiratory volume in one second(FEV1),percentage of forced expiratory volume in the first second(FEV1%),forced expiratory volume/forced vital capacity in the first second(FEV1/FVC)and maximum expiratory flow(PEF)were analyzed and compared between the two groups.Results There were significant differences in FVC,FEV1,FEV1/FVC and PEF between the two groups.The lung function related indexes of children withⅢosteogenesis imperfection were lower than those of children in the control group,and there was a statistical difference(P<0.05).Conclusion FVC,FEV1,PEF,FEV1/FVC in children with typeⅢosteogenesis imperfecta were significantly lower than those in children without pulmonary disease in the control group.
作者 侯振齐 Hou Zhenqi(Tianjin Wuqing District People's Hospital,Tianjin 301700,China)
出处 《首都食品与医药》 2024年第16期18-21,共4页 Capital Food Medicine
基金 天津市武清区科技计划发展项目资助(编号:WQKJ201729)。
关键词 成骨不全 用力肺活量 一秒钟用力呼气量 最大呼气流量 肺功能 osteogenesis imperfecta Forced vital capacity Forced expiratory volume in one second Maximum expiratory flow Pulmonary function
  • 相关文献

参考文献1

二级参考文献5

  • 1Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfect. J Med Genet 1979; 16: 101-16. doi: 10.11361 jmg.16.2.1 0 I. 被引量:1
  • 2Lindahl K, Langdahl B, Ljunggren o, Kindmark A. Treatment of osteogenesis imperfecta in adults. Eur J Endocrinol20 14; 171 :R 79-90. doi: 10.1530/EJE-14-0017. 被引量:1
  • 3Lund AM, Jensen BL, Nielsen LA, Skovby F. Dental manifestations of osteogenesis imperfecta and abnormalities of collagen I metabolism. J Craniofac Genet Dev Bioi 1998;18:30-7. 被引量:1
  • 4Rose NJ, Mackay K, Byers PH, Dalgleish R. A Gly238Ser substitution in the alpha 2 chain of type I collagen results in osteogenesis imperfecta type III. Hum Genet 1995;95:215-8. 被引量:1
  • 5Lee KS, Song HR, Cho TJ, Kim HJ, Lee TM, Jin HS, et al. Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta. Hum Mutat 2006;27:599. doi: 10.1002Ihumu.9423. 被引量:1

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部